Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids
出版年份 2021 全文链接
标题
Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids
作者
关键词
Sonic hedgehog, Tumor microenvironment, Myeloid derived suppressor cells, Cytotoxic T lymphocytes
出版物
CANCER LETTERS
Volume 518, Issue -, Pages 59-71
出版商
Elsevier BV
发表日期
2021-06-12
DOI
10.1016/j.canlet.2021.06.007
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
- (2020) M. Moehler et al. ANNALS OF ONCOLOGY
- MiR130b from Schlafen4+ MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer
- (2020) Lin Ding et al. GUT
- VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
- (2020) Elizabeth Smyth et al. Frontiers in Oncology
- Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study
- (2020) Akihito Kawazoe et al. EUROPEAN JOURNAL OF CANCER
- Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
- (2020) Zi Mei et al. International Journal of Oral Science
- PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
- (2020) Sadegh Fattahi et al. LIFE SCIENCES
- Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection
- (2019) Loryn Holokai et al. PLoS Pathogens
- KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
- (2019) Yung-Jue Bang et al. Future Oncology
- High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling
- (2019) Maria I. Toki et al. CLINICAL CANCER RESEARCH
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial
- (2019) Sandra Demaria et al. Journal for ImmunoTherapy of Cancer
- Regenerative proliferation of differentiated cells by mTORC1‐dependent paligenosis
- (2018) Spencer G Willet et al. EMBO JOURNAL
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
- (2018) Liru Wang et al. OncoImmunology
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
- (2018) Peng-Fei Wang et al. OncoImmunology
- Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer
- (2018) Jayati Chakrabarti et al. Oncotarget
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- Organoid Models of Human Gastrointestinal Development and Disease
- (2016) Priya H. Dedhia et al. GASTROENTEROLOGY
- Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
- (2016) Yaqing Zhang et al. GUT
- Schlafen 4–expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia
- (2016) Lin Ding et al. JOURNAL OF CLINICAL INVESTIGATION
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- CD44 Plays a Functional Role in Helicobacter pylori-induced Epithelial Cell Proliferation
- (2015) Nina Bertaux-Skeirik et al. PLoS Pathogens
- Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
- (2015) Oana Draghiciu et al. OncoImmunology
- Helicobacter pylori-induced Sonic Hedgehog Expression is Regulated by NFκB Pathway Activation: The Use of a Novel In vitro Model to Study Epithelial Response to Infection
- (2014) Michael A. Schumacher et al. HELICOBACTER
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer
- (2013) Zhaode Bu et al. CURRENT CANCER DRUG TARGETS
- The Acid-Secreting Parietal Cell as an Endocrine Source of Sonic Hedgehog During Gastric Repair
- (2013) Amy C. Engevik et al. ENDOCRINOLOGY
- Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells
- (2013) Elio Schouppe et al. IMMUNOBIOLOGY
- Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
- (2013) Robert Wesolowski et al. Journal for ImmunoTherapy of Cancer
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- Gastric Sonic Hedgehog Acts as a Macrophage Chemoattractant During the Immune Response to Helicobacter pylori
- (2012) Michael A. Schumacher et al. GASTROENTEROLOGY
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Sonic Hedgehog contributes to gastric mucosal restitution after injury
- (2012) Chang Xiao et al. LABORATORY INVESTIGATION
- Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
- (2012) D Mougiakakos et al. LEUKEMIA
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
- (2010) M. G. Lechner et al. JOURNAL OF IMMUNOLOGY
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now